无精子症因子c微缺失与辅助生殖技术结局:系统综述与Meta分析
该系统综述与Meta分析检索至2023年4月的病例对照研究,基于3807名男性数据,比较伴与不伴AZFc微缺失的不育男性的取精率和辅助生殖技术结局。伴AZFc微缺失者取精率与对照无统计学显著差异,但受精率、临床妊娠率和活产率显著更低;校正女性因素后受精率、卵裂率、临床妊娠率和活产率仍显著更低。
要点
- 伴AZFc微缺失的不育男性取精率与无缺失者无统计学显著差异(OR=1.82,95%CI 0.97, 3.41)。
- 伴AZFc微缺失者受精率、临床妊娠率和活产率显著低于无缺失者。
- 校正女性因素后,伴AZFc微缺失者受精率、卵裂率、临床妊娠率和活产率仍显著更低。
核心结论
- AZFc微缺失的存在对不育男性的辅助生殖技术结局产生不利影响。
- 需要进一步深入研究AZF基因在胚胎发育中的作用,以理解该发现的完整影响。
研究设计与样本
- 系统综述与Meta分析,检索电子数据库截至2023年4月的病例对照研究,报告伴与不伴AZFc微缺失不育男性的取精率和辅助生殖技术结局。
- 采用纽卡斯尔-渥太华量表评估研究质量,计算汇总效应量(比值比OR及95%置信区间CI)。
- 基于3807名男性的数据进行分析。
主要发现
- 伴AZFc微缺失男性取精率高于无缺失对照(OR=1.82,95%CI 0.97, 3.41),但差异无统计学意义。
- 伴AZFc微缺失男性受精率(OR=0.61,95%CI 0.50, 0.74)、临床妊娠率(OR=0.61,95%CI 0.42, 0.89)和活产率(OR=0.54,95%CI 0.40, 0.72)显著低于无缺失男性。
- 两组间胚胎卵裂率、囊胚形成率、优质胚胎率、种植率和流产率无统计学显著差异。
- 校正女性因素后,伴AZFc微缺失男性受精率(OR=0.76,95%CI 0.71, 0.82)、卵裂率(OR=0.54,95%CI 0.41, 0.72)、临床妊娠率(OR=0.39,95%CI 0.30, 0.52)和活产率(OR=0.48,95%CI 0.35, 0.65)仍显著低于对照。
- 未检索到报告AZFa和AZFb缺失男性取精率及辅助生殖技术结局的病例对照研究。
关键数值与推荐
- 取精率:伴AZFc微缺失 vs 无缺失,OR=1.82(95%CI 0.97, 3.41),差异无统计学意义。
- 受精率:伴AZFc微缺失 vs 无缺失,OR=0.61(95%CI 0.50, 0.74),显著降低。
- 临床妊娠率:伴AZFc微缺失 vs 无缺失,OR=0.61(95%CI 0.42, 0.89),显著降低。
- 活产率:伴AZFc微缺失 vs 无缺失,OR=0.54(95%CI 0.40, 0.72),显著降低。
- 校正女性因素后:受精率OR=0.76(95%CI 0.71, 0.82)、卵裂率OR=0.54(95%CI 0.41, 0.72)、临床妊娠率OR=0.39(95%CI 0.30, 0.52)、活产率OR=0.48(95%CI 0.35, 0.65),均显著低于对照。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未检索到报告AZFa和AZFb缺失男性取精率及辅助生殖技术结局的病例对照研究。
- 需要进一步深入研究AZF基因在胚胎发育中的作用,以理解该发现的完整影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether Azoospermia Factor c (AZFc) microdeletions affect Assisted Reproductive Technology (ART) outcomes. DESIGN: Systematic review and meta-analysis. SETTING: Not applicable. PATIENTS: Infertile men with and without AZFc microdeletions. INTERVENTION(S): Electronic databases were searched for case-control studies reporting sperm retrieval rates and outcomes of ART in infertile men with and without AZFc microdeletions from inception to April 2023. Study quality was assessed using the Newcastle-Ottawa Scale. Summary effect sizes (odds ratio [OR] with 95% confidence interval [CI]) were calculated for both categories of infertile men. MAIN OUTCOME MEASURES: The primary outcome was successful sperm retrieval and the secondary outcomes were outcomes of ART. RESULTS: Case-control studies reporting sperm retrieval rates and ART outcomes in men with AZFa and AZFb deletions were unavailable. On the basis of the data from 3,807 men, sperm retrieval rates were found to be higher in men with AZFc microdeletions compared to their non-deleted counterparts [OR = 1.82, 95% CI 0.97, 3.41], but the difference was not statistically significant. A significantly lower fertilization rate (OR = 0.61, 95% CI [0.50, 0.74]), clinical pregnancy rate (OR = 0.61, 95% CI [0.42, 0.89]), and live birth rate (OR = 0.54, 95% CI [0.40, 0.72]) were observed in men with AZFc deletions compared with men without deletions. There was no statistically significant difference in rates of embryo cleavage, blastocyst formation, good-quality embryos, implantation, and miscarriage between the two groups. On correcting for female factors, the fertilization rate (OR = 0.76, 95% CI [0.71, 0.82]), cleavage rate (OR = 0.54, 95% CI [0.41, 0.72]), clinical pregnancy rate (OR = 0.39, 95% CI [0.30, 0.52]), and live birth rate (OR = 0.48, 95% CI [0.35, 0.65]) were significantly lower in men with AZFc deletions compared with controls. CONCLUSIONS: Presence of AZFc microdeletions adversely affects outcomes of ART in infertile men. Further in-depth studies delineating the role of the AZF genes in embryonic development are necessary to understand the full-impact of this finding. CLINICAL TRIAL REGISTRATION NUMBER: CRD42022311738.
引用
- Colaco S, Modi D. Azoospermia factor c microdeletions and outcomes of assisted reproductive technology: a systematic review and meta-analysis. Fertil Steril. 2023. PMID: 37923163. doi:10.1016/j.fertnstert.2023.10.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。